Trial · NCT00103857
Participant flow42
How many started, completed or left each group, period by period.
1 to 20 of 42
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| 54-Week Base Study | STARTED | Sitagliptin 100 mg q.d. | 179 | |
| 54-Week Base Study | STARTED | Metformin 500 mg b.i.d. | 182 | |
| 54-Week Base Study | STARTED | Metformin 1000 mg b.i.d. | 182 | |
| 54-Week Base Study | STARTED | Sitagliptin 50 mg b.i.d. + Metformin 500 mg b.i.d. | 190 | |
| 54-Week Base Study | STARTED | Sitagliptin 50 mg b.i.d + Metformin 1000 mg b.i.d. | 182 | |
| 54-Week Base Study | STARTED | Placebo/Metformin 1000 mg b.i.d. | 176 | |
| 54-Week Base Study | STARTED | Sitagliptin 50 mg b.i.d + Metformin 1000 mg b.i.d. OLC | 117 | |
| 54-Week Base Study | COMPLETED | Sitagliptin 100 mg q.d. | 122 | |
| 54-Week Base Study | COMPLETED | Metformin 500 mg b.i.d. | 126 | |
| 54-Week Base Study | COMPLETED | Metformin 1000 mg b.i.d. | 135 | |
| 54-Week Base Study | COMPLETED | Sitagliptin 50 mg b.i.d. + Metformin 500 mg b.i.d. | 148 | |
| 54-Week Base Study | COMPLETED | Sitagliptin 50 mg b.i.d + Metformin 1000 mg b.i.d. | 141 | |
| 54-Week Base Study | COMPLETED | Placebo/Metformin 1000 mg b.i.d. | 115 | |
| 54-Week Base Study | COMPLETED | Sitagliptin 50 mg b.i.d + Metformin 1000 mg b.i.d. OLC | 79 | |
| 54-Week Base Study | NOT COMPLETED | Sitagliptin 100 mg q.d. | 57 | |
| 54-Week Base Study | NOT COMPLETED | Metformin 500 mg b.i.d. | 56 | |
| 54-Week Base Study | NOT COMPLETED | Metformin 1000 mg b.i.d. | 47 | |
| 54-Week Base Study | NOT COMPLETED | Sitagliptin 50 mg b.i.d. + Metformin 500 mg b.i.d. | 42 | |
| 54-Week Base Study | NOT COMPLETED | Sitagliptin 50 mg b.i.d + Metformin 1000 mg b.i.d. | 41 | |
| 54-Week Base Study | NOT COMPLETED | Placebo/Metformin 1000 mg b.i.d. | 61 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00103857/flow